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AF10 (10p12) - Courtesy Mariano Rocchi, Resources for 
Molecular Cytogenetics.  
DNA/RNA 
Transcription 
5' telomeric → 3' centromeric direction; 5.5 kb mRNA; 
coding sequence: 3.1 kb. 
Protein 
Description 
1027 amino acids; 109 KDa; N-term - LAP (leukemia 
associated protein)/PHD finger - Ext-LAP/PHD (Cys-
rich region) - NLS (nuclear localisation signal) - AT-
hook - LZ (leucine zipper) - Gln-rich domain - C-term. 
Expression 






With AF17 and BR140. 
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Representation of the AF10 protein modified by Linder B et al. J Mol Biol 2000 and Jones LK et al. Leukemia 2001. 
 
Implicated in 
t(10;11)(p12;q23)/ANLL → MLL-AF10 
Disease 
Mainly M4/M5 ANLL. 
Cytogenetics 
Due to the opposite orientation of AF10 and MLL on 
their respective chromosome arms, MLL-AF10 gene 
fusion requires complex rearrangements with three or 
more breakpoints. An inversion of the 5'MLL or 
3'AF10 is required in order to allow an in-frame MLL-
AF10 fusion. 
Hybrid/Mutated Gene 
5' MLL - 3' AF10; breakpoints are at variable places 
along AF10. 
Abnormal Protein 
The AF10 Ext-LAP/PHD is always deleted, as are the 
MLL PHD fingers. Both retain the C-term LZ domain 
necessary for malignant transformation. 
inv ins(10;11)(p12;q23q12)/ANLL → 
MLL-AF10 
Disease 
One case of pediatric M5 ANLL. 
Hybrid/Mutated Gene 
5' MLL - 3' AF10 and 5' AF10 - 3' HEAB, a gene at 
11q12. 
Abnormal Protein 
Only MLL-AF10 is expressed. 
t(10;11)(p13;q14-21) → CALM -AF10 
and/or AF10-CALM 
Disease 
Present both in myeloid and non myeloid acute 
leukemias: in T-cell ALL specific to TCRgd lineage; in 
myeloid leukemia described in FAB M0-AML, M1-









May well be confused with the above 
t(10;11)(p12;q23). 
Hybrid/Mutated Gene 
5' CALM - 3' AF10 and 5' AF10 - 3' CALM. 
In a 5' breakpoint cluster region (nucleotides 424 and 
589), AF10 sequences retained the Ext-LAP/PHD 
domain. The presence of these kinds of sequences 
seems to be necessary for maturation toward the 
TCRgd lineage, whereas their absence leads to 
maturation arrest at a more immature stage. 
Abnormal Protein 
Both CALM-AF10 and the reciprocal AF10-CALM are 
expressed. However, the CALM-AF10 contains most 
of the functional domains present in each of the two
proteins. 
Breakpoints 
Note: the breakpoint in the t(10;11)(p13;q14-21) is 
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